Ribavirin
Editor:
- J.K. AronsonJAJ.K. Aronson
- 21 October 2015
- book chapter
- Published by Elsevier
- p. 115-129
Abstract
No abstract availableThis publication has 136 references indexed in Scilit:
- Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2011
- The incidence, predictors and management of anaemia and its association with virological response in HCV / HIV coinfected persons treated with long-term pegylated interferon alfa 2a and ribavirinAlimentary Pharmacology & Therapeutics, 2011
- Serous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis CCase Reports in Ophthalmology, 2011
- Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose ReductionGastroenterology, 2010
- HIV/Hepatitis C Virus−Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders DoJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Expectoration of Large Bronchial Casts Secondary to the Treatment of Chronic Hepatitis C With Pegylated Interferon and RibavirinClinics, 2010
- Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis C: a Review of the LiteratureDigestive Diseases and Sciences, 2009
- Pneumococcal Meningitis during Antiviral Treatment with Interferon and Ribavirin in a Splenectomized Patient with Chronic Hepatitis C - Do Not Miss Vaccination before Starting TherapyZeitschrift für Gastroenterologie, 2008
- Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirinEuropean Journal of Gastroenterology & Hepatology, 2008
- Anecdotes that provide definitive evidenceBMJ, 2006